Prostate News Archive
06-Aug-2006
Immunogenic Peptides for the Treatment of Prostate and Breast Cancer (Pharmalicencing)
This invention relates to antigenic sequences of the T cell receptor gamma alternate reading frame protein (TARP). TARP is expressed in breast cancer cells and prostate cancer cells. Spectrum Pharmaceuticals Announces Phase 2 Data For Ozarelix In Hormone-Dependent Prostate Cancer (Medical News Today)
SpectrumPharmaceuticals, Inc. (Nasdaq: SPPI) today announced data from its Phase 2trial with ozarelix for patients suffering from hormone-dependent prostatecancer. In this study, ozarelix was administered intramuscularly in 65, 100 or130 mg according to different dosing schedules and repeated for 3 cycles of28 days. [click link for full article] Nanoparticles Annihilate Prostate Cancer (Scientific American)
Fighting cancer is currently a messy war. Modern chemotherapies attack tumors with the equivalent of a machinegun approach: cover the area widely with deadly fire and hope to destroy the tumor with a minimum of collateral damage. Altering Fatty Acid Levels In Diet May Reduce Prostate Cancer Growth Rate, UCLA Study Shows (Medical News Today)
UCLA researchers found that altering the fatty acid ratio found in the typical Western diet to include more omega-3 fatty acids and decrease the amount of omega-6 fatty acids may reduce prostate cancer tumor growth rates and PSA levels. [click link for full article] Tree bark could target prostate cancer (San Antonio Express News)
Scientists all over the globe are scouring rainforests and ocean floors, looking for natural compounds that may help fight cancer. Now, some San Antonio researchers say evidence shows a particular kind of tree bark may be able to kill prostate cancer cells. Fear Factor in Early Prostate Cancer (WebMD)
Men with early prostate cancer may choose treatments based partly on fear and misconceptions about their options.
Back to Prostate News Archive
